SIGLEC1 and Smith-Magenis syndrome: Moreover, genetic interferonopathies of type I IFN, have been associated with high levels of monocytic CD169 in childhood autoimmune Aicardi Goutière syndrome (AGS) and Singleton-Merten syndrome (SMS) and therefore monocytic CD169 has been proposed as an effective screening marker (65).